Cholesteryl ester transfer activity is increased in plasma of cholesterol-fed rabbits. To investigate the mechanisms leading to changes in activity, we measured cholesteryl ester transfer protein (CETP) mass by RIA and CETP mRNA abundance by Northern and slot blot analysis using a human CETP cDNA probe in control (n = 8) and cholesterol-fed rabbits (n = 10). Cholesterol feeding (chow plus 0.5% cholesterol, 10% corn oil) for 30 d increased CETP mass in plasma 3.2-fold in the cholesterol-fed rabbits (12.45±0.82 ;g/ml) compared with controls (3.86±038 pg/ml). In the hypercholesterolemic rabbit, liver CETP mRNA levels were increased 2.8 times control mRNA levels. Actin, apo E, lecithin-cholesterol acyltransferase, and albumin mRNA abundances were unchanged. In contrast to the widespread tissue distribution in humans, CETP mRNA was not detected in extrahepatic tissues of either control or cholesterol-fed animals. Using a sensitive RNase protection assay, the increase in liver CETP mRNA was detectable within 3 d of beginning the high cholesterol diet. Thus, in response to the atherogenic diet there is an early increase in liver CETP mRNA, probably causing increased CETP synthesis and secretion, and increased plasma CETP. 
Introduction
1. Abbreviations used in this paper: CE, cholesteryl ester; CETP, cholesteryl ester transfer protein; LCAT, lecithin:cholesterol acyltransferase.
cron remnant receptor (1) , the CETP provides a mechanism for returning CE, formed in HDL by the lecithin:cholesterol acyltransferase (LCAT) reaction, to the liver. This provides a pathway for returning plasma CE to liver, which can function independently of liver LDL receptor-mediated clearance (2). Although this pathway could have an antiatherogenic function, it may also promote the accumulation of CE in foam cell-forming VLDL or chylomicron remnants (2, 3). Thus, in circumstances where there is impaired clearance of remnants (e.g., in human dysbetalipoproteinemia), the plasma CE transfer pathway may indirectly contribute to atherogenesis.
Efforts to understand the function and regulation of CETP have led to the purification of a Mr 74,000 protein (4) from human plasma and the production of MAbs to the CETP that neutralize its CE and triglyceride transfer activities (5) . The human CETP cDNA has been isolated and used to determine the sequence and expression of the mRNA (6) . The cDNA hybridizes to a 1.9-kb transcript in human liver and small intestine, apparently the two major sources of apoprotein synthesis in humans, given the large size ofthese organs. However, comparable or larger concentrations of CETP mRNA were also found in human adrenal gland and spleen (6) . Recently, the cloning and sequencing of the rabbit CETP cDNA identified a highly homologous 2.2-kb mRNA that was found in liver but not in other tissues (7) .
At present, little is known about the regulation of plasma CETP activity or mass levels. Increased CE transfer activity was found in hypercholesterolemic plasma obtained from cholesterol-fed rabbits (3, 8) . Alterations in CE transfer activity have been documented in a variety of nutritional states, and during pregnancy (9) or drug therapy (10) . However, activity measurements are influenced by factors such as inhibitors ( 11) and cannot be equated with CETP mass. The recent development of MAbs to CETP (5) and the availability of a cDNA (6) now permit an understanding of CETP on a molecular level.
The aims of the present study were (a) to determine if previously documented changes in activity (3, 8) were due to changes in CETP mass, and (b) to measure CETP mRNA changes in response to the atherogenic diet. The changes in CETP mass have been measured by MAb-based RIA, and the human CETP cDNA probe has been used to assess the levels of CETP mRNA in rabbit liver and peripheral tissues. The results show an increase in plasma CETP mass and also a corresponding increase in CETP mRNA in rabbit liver, and suggest that the CETP gene may be subject to dietary regulation.
Methods

Animals
Male New Zealand white rabbits weighing 2.5-3 kg were used in all experiments. All animals were housed individually and had free access to water. Experiments were performed on three different groups of rabbits.
1-mo cholesterolfeeding study. 10 rabbits were fed the high cholesterol diet (rabbit chow supplemented with 0.5% cholesterol and 10% corn oil), and 8 rabbits were fed the control diet (standard milled rabbit chow) for 1 mo before killing. Blood was obtained in heparinized tubes from the ear vein, and the plasma separated and frozen at -70'C. Organs were removed, frozen immediately in liquid N2, and stored at -70'C until analyzed.
Time-course study. To evaluate the time course of changes in plasma CETP and liver mRNA levels, pairs of rabbits were killed at various times after beginning the high cholesterol diet (at 0, 3, 5, 7, 10, 14, and 30 d).
Lovastatin study. To evaluate the effect of plasma cholesterol levels on CETP, four rabbits fed control chow were given lovastatin and compared with a simultaneous control group of four rabbits receiving no drug. Lovastatin (Merck and Co., Rahway, NJ) was administered orally (30- 
Cholesterol measurements
Total serum cholesterol was assayed enzymatically at 500 nm using reagents (Sigma Chemical Co., St. Louis, MO) and a modification of the method of Allain et al. (12) .
CETP mass measurements CETP mass was assayed by solid-phase competitive RIA (13) with the following modifications. Plastic wells were coated overnight with 30 ng purified CETP in 15 mM Na2CO3, 35 mM NaHCO3, and 0.02% NaN3, pH 9.6. A standard plasma pool was prepared from 10 normolipemic human donors, made 2 mM in diethylparanitrophenyl phosphate, and stored in aliquots at -70'C. The standard plasma pool was calibrated using purified CETP and had a concentration of 1.8 .g/ml.
Before assaying standard plasma, all samples were incubated for 1 h at 370C in an equal volume of 2% Triton saturation buffer (PBS with 2% Triton X-100, 1% BSA, 0.02% NaN3, and 1 mM EDTA, pH 7.2). MAb TP-2 and antigens were diluted in 1% Triton saturation buffer to give a final assay concentration of 0.5% Triton. Before counting, wells were washed three times with 0.5% Triton saturation buffer.
To ensure that the assay was not influenced by lipoproteins, the d < 1.21 g/ml fraction and the d > 1. 21 
Statistics
Results are given as mean±SEM values, and the significance of the differences of mean values is assessed by t test. Two-way analysis of variance and simple correlation analysis were performed using a standard software package.
Results CETP mass measurements in rabbit plasma. A competitive solid-phase RIA using the human CETP MAb TP-2 (5) was used to measure CETP mass in rabbit plasma. It was anticipated that rabbit CETP would be well recognized by TP-2 since the sequence of rabbit CETP is almost identical to human CETP in the region of the epitope (7). To validate the assay for rabbit CETP, the displacement curves of control and cholesterol-fed rabbit plasma samples were compared with a standard human plasma pool of known CETP mass. Normolipemic and hypercholesterolemic rabbit plasmas (data points represented by circles and squares) produced displacement curves that were parallel to the standard human plasma pool (X's; Fig. 1 ) in the RIA. The curve for undiluted cholesterolfed rabbit plasma was markedly displaced from the standard curve, indicating a higher mass ofCETP (Fig. 1, open squares) . Subsequent assays of the plasma from cholesterol-fed rabbits were performed at a 1:10 dilution (solid squares), which also gave a displacement curve parallel to the human control. Other experiments showed that the markedly increased lipoprotein fraction in the plasma ofcholesterol-fed rabbits did not interfere in the assay (see Methods). These preliminary experiments showed that the RIA was suitable for quantitation of CETP in rabbit plasma, and suggested a pronounced increase in mass of CETP in cholesterol-fed rabbit plasma compared with control.
The RIA was then used to evaluate the levels of CETP in plasma of 10 cholesterol-fed and 8 control animals. The mean plasma cholesterol levels in rabbits fed cholesterol for 30 d was 1,539±238.3 mg/dl, compared with 42.13±8.45 mg/dl for rabbits fed the chow diet for the same period. The RIA for CETP revealed that cholesterol feeding increased CETP plasma levels approximately threefold (P < 0.001) in the hy- percholesterolemic rabbits (12.45±0.82 Ag/ml) compared with controls (3.86±0.38 gg/ml). CETP mRNA levels in rabbit liver. To investigate the mechanism ofthe increase in plasma CETP mass we measured the relative abundance of CETP mRNA in livers of cholesterol-fed and control rabbits. Initially, cross-hybridization of the human CETP cDNA probe with mRNA from rabbit liver was assessed by Northern blot analysis. Poly A+ mRNA prepared from either human spleen (Fig. 2 A) (the richest source of human CETP mRNA [6] ), control rabbit liver (Fig. 2 B) , or cholesterol-fed rabbit liver (Fig. 2 C) was hybridized with a 32P-labeled human CETP cDNA probe. The human CETP mRNA appears as a single transcript of 1.9 kb, while the rabbit liver CETP mRNA was slightly larger, 2.2 kb, as reported (6, 7) . These results showed that the human CETP cDNA probe could be used specifically to measure rabbit CETP mRNA. Cholesterol feeding ofthe rabbits resulted in a two-to threefold increase in abundance of the 2.2-kb CETP mRNA (Fig. 2 C) . Similar results were obtained in three separate Northern blot analyses.
Quantitation of CETP mRNA levels in 1-mo cholesterol feeding study. Using conditions that gave a specific signal for the CETP mRNA (see Fig. 2 ), slot blot hybridization was used to analyze samples from larger numbers of animals. Poly A+ RNA was extracted from 8 control and 10 cholesterol-fed rabbit livers, pooled, and slot blotted, and the filters were probed with 32P-labeled CETP cDNA. There was a linear response of the hybridization signal with increasing amounts of RNA applied to the slot blot (Fig. 3) . As determined from the difference in the slopes (P < 0.001), there was a 2.6-fold increase in liver CETP mRNA in cholesterol-fed rabbits compared with The autoradiogram of a slot blot probed with 32P-labeled CETP cDNA, comparing individual liver mRNA samples from 10 cholesterol-fed to 8 control rabbits is shown in Fig. 4 A. Despite some variability among animals, the specific CETP hybridization signal was noticeably increased in the majority of the hypercholesterolemic rabbits compared with the controls. The CETP mRNA signal was increased (P < 0.01) from 1.54±0.20 arbitrary absorbance units in control rabbit liver to 4.33±0.60 arbitrary absorbance units in cholesterol-fed rabbit livers. Rehybridization of the same blots with chicken i3-actin cDNA probe showed that liver fl-actin mRNA abundance was unaltered (P > 0.5) in the rabbits fed high cholesterol diets (1.1±0.13 relative units) when compared with the controls (1.33±0.17 relative units). The liver CETP/actin mRNA ratio in rabbits fed high cholesterol diets was 2.8±0.6 times that of controls (P < 0.05 by t test), suggesting a specific increase in CETP mRNA in response to the high cholesterol diet.
Since actin mRNA levels may vary substantially under certain conditions (23, 24) , the same filters were also hybridized with [32P]oligo (dT)15 to normalize signal strength for the amount of poly A+ mRNA bound to each slot. The results were identical using either actin or oligo (dT) probes, i.e., there was no change in signal with cholesterol feeding. Hybridiza-B tion of liver mRNA samples with cDNA probes to albumin, apo E, and LCAT demonstrated that the abundance of these mRNAs was unaltered by the high cholesterol diet (not shown). These observations indicate that the increase in CETP mRNA is not a general response of liver proteins or apolipoproteins to the high cholesterol diet.
Tissue distribution of CETP mRNA with cholesterolfeeding. Slot blot hybridization of poly A+ RNA from different tissues (Fig. 5) confirms that the liver is the major site of synthesis of CETP mRNA in the chow-fed rabbit, as recently reported (7). Liver CETP mRNA levels were induced about threefold with cholesterol feeding as expected. However, the other tissues gave only a faint signal, close to the limit of detection, or no signal, in both control and cholesterol-rich diets (Fig. 5 A) . Poly A+ mRNA from spleen and heart, which gave faint nonspecific hybridization signals by slot blot analysis, failed to demonstrate any specific signals by Northern blot analysis, even at higher levels of RNA than those used in slot blot analysis (data not shown).
[32P]Oligo (dT) hybridization of the washed slot blot filter showed that similar amounts of poly A+ mRNA had been bound to the nitrocellulose for the different tissues (Fig. 5 B) . Thus, in contrast to human CETP mRNA, which is found in liver and also in the small intestine, adrenal, and spleen (6), rabbit CETP mRNA in both control and cholesterol-fed rabbits is restricted to the liver.
Relationship of liver CETP mRNA and plasma CETP mass. The RIA values for the 1-mo cholesterol feeding study were related to the relative mass of CETP mRNA for the 10 individual cholesterol-fed rabbits and 8 controls (Fig. 6) . Regression analysis of the data revealed that plasma CETP mass and liver CETP mRNA levels were significantly correlated with an r value of 0.71 (P < 0.005 by F test). However, inspection of the data (Fig. 6 ) reveals that the regression line is heavily influenced by the clustering of low values in the chowfed animals, and there does not appear to be a significant correlation between CETP mass and mRNA within each group. Thus, the data suggest that the increase in CETP mRNA is in part responsible for the increase in CETP mass in cholesterol-fed animals, but that other factors also contribute to variability in CETP levels. Time course ofchanges in CETP mRNA. To document the temporal changes in liver CETP mRNA, an RNase protection-solution hybridization assay was developed (see Methods). Such assays are more sensitive and precise than Northern or slot blots and can be performed on total RNA. The RNase digestion resulted in a protected fragment of the expected size (Fig. 7) , which was quantitated. The time course ofchanges in liver CETP mRNA and ofplasma cholesterol are shown in Fig. 8 . Each point represents the mean±SEM value (offour separate assays performed on two rabbits killed at each time point). The data indicate an increase in CETP mRNA, detectable at the earliest time point (3 d, P < 0.05 compared with day 0), and gradually increasing to a value 2.9 times the control (day 0) at 30 d.
Lovastatin study. Lovastatin, a hypocholesterolemic compound that inhibits cholesterol biosynthesis, has been shown to lower CETP activity in rabbits (10) . Therefore, lovastatin was administered to rabbits for 7 d to determine if the druginduced hypocholesterolemia was associated with decreased levels of CETP mass, and to further examine the relationship between CETP mass and mRNA levels. Basal levels of cholesterol and CETP mass were measured in pretreatment plasmas of control (n = 4) and lovastatin-treated (n = 4) animals. To identify the drug-induced changes in plasma cholesterol the values were expressed as percentages of the respective pretreatment (basal) values. No significant changes in either CETP mass or mRNA levels were found with lovastatin treatment despite a decrease in plasma cholesterol to 49.5±6.02% (P . 0.005 by t test) of basal values in the lovastatin-treated group.
Discussion
In this study we have documented a pronounced increase in the mass of CETP in hypercholesterolemic rabbit plasma, clearly showing that changes in plasma CE transfer activity (3, This study was prompted by the finding of increased CE transfer activity in the plasma of rabbits fed high cholesterol, high fat (3, 8) , or saturated fat diets (8) . Several factors influence CETP activity, such as inhibitory proteins ( 11) or changes in substrate composition (25) . However, the present study documents for the first time an increase in CETP mass by a definitive approach (RIA). The increase in CETP (three times) is sufficient in magnitude to account for a two-to fourfold increase in CETP activity (previously noted in reference 3).
An increase in plasma CETP mass could be brought about either by changes in half-life, or by an increase in the synthesis rate of the CETP associated with more abundant CETP mRNA. Increased CETP production (versus catabolism) seems a sufficient explanation for the substantial difference in CETP levels seen in hypercholesterolemia, since the threefold increase in plasma CETP levels as measured by RIA were similar in magnitude to mRNA increases in the rabbit liver. However, there was considerable variability in CETP mRNA levels among cholesterol-fed animals with similar plasma CETP levels (Fig. 6) , suggesting that other factors may also influence plasma CETP.
In general, hepatic CETP mRNA levels (7) seem to correlate with variations in plasma CETP mass or activity in different species (26) as well as in the cholesterol-fed rabbit, implying that liver synthesis also plays a major role in explaining species differences in plasma CETP levels and activity. For example, plasma CETP mass (determined by RIA) was approximately two times higher in rabbit plasma than in humans ( Fig. 1) and five-to tenfold higher in monkey plasma than in human, in parallel with comparative abundance ofCETP liver mRNA for both species (unpublished results). An additional source in humans could be extrahepatic synthesis in the small intestine, adrenal gland, or spleen. CETP mRNA could arise from activated lymphocytes or macrophages (27) in the spleen. The CETP mRNA in rabbit liver could be present in hepatocytes or tissue macrophages. However, the absence of detectable CETP mRNA in rabbit spleen (Fig. 5) suggests that macrophages are not likely to be a source of CETP mRNA in the rabbit. The detection of CETP mRNA in isolated hepatocytes (6) and the synthesis of CETP in HepG2 cells (28, 29) implies that hepatocytes may be responsible for CETP synthesis within the liver.
Although a large number of genes play important roles in the metabolism of lipoproteins (30) , only a limited number of genes have been found to have altered expression in response to dietary changes. For example, in the rabbit fed high cholesterol diets there are marked increases in the plasma levels of apo E and apo B, but liver mRNA levels for apo E are unchanged (31) and apo B mRNA levels are actually decreased (32) . Differences in apo E and B plasma levels, therefore, are more closely related to differences in their fractional catabolic rates resulting from downregulation of hepatic LDL receptors (31, 32) . The tandem linkage ofthe genes for CETP and LCAT at chromosome 16q12-2 1 and 16q22, respectively (33, 34) , and the related functions of their gene products, suggested to us that the LCAT gene might be coordinately regulated with CETP. However, in rabbit liver, LCAT as well as albumin, actin, and apo E mRNA levels did not change with cholesterol feeding in the present study.
CETP activity has been reported to be altered in a variety of different nutritional states (3, 8) and in pregnancy (9), suggesting that CETP gene expression might be sensitive to a variety of dietary, drug, or hormonal stimuli. However, CETP activity measurements are influenced by several factors other than mass, and further studies are required. In the present study we failed to find an effect of lovastatin on CETP mass, in contrast to a decrease in CETP activity previously noted (10) . This could be because activity measurements were influenced by some other change (e.g., the decrease in HDL mass [10] ).
CETP has been shown to play a significant rate-limiting role in the catabolism of HDL CE in the rabbit, probably promoting the movement of CE from plasma to the liver (35). The major physiological role of CETP may be to transfer the LCAT-derived CE to a pool of triglyceride-rich lipoproteins which undergo rapid catabolism and hepatic uptake by the chylomicron remnant receptor, or get converted into IDL or LDL and taken up by the LDL receptor. Since the HDL CE are derived in part from phospholipids and cholesterol transferred into HDL from the surface of triglyceride-rich lipoproteins during lipolysis (36) , the activity of CETP may be seen as a way of returning chemical moieties of surface lipids of triglyceride-rich lipoproteins to the liver. The CETP pathway has the potential to recycle CE to the liver independent ofthe LDL receptor, and thus may be particularly important when the LDL receptor is downregulated, such as in response to the atherogenic diet. This may provide a potential teleological explanation for the induction of CETP mRNA and mass in response to the atherogenic diet.
